NCT07046104

Brief Summary

ABSTRACT Background: mandibular class 1 modification 1 RPD can be retained by mesially placed implant only, or canines can be used to share in retention using telescopic attachment. So, the aim of this clinical study is to evaluate patient satisfaction and oral health impact profile (OHIP-14) for implant retained Overdenture versus implant-tooth retained Overdenture. Methods: This clinical cross-over study included 10 partially edentulous patients with only remaining mandibular canines. Every patient received two mandibular implants at the 1st premolar region. Two mandibular implant retained overdenture will be constructed, opposing a maxillary single denture. One of the dentures was made with a design based on implant retention only but the other denture was made with dual implant-tooth retention design. The effects of each overdenture design were evaluated after 3 months. patients indicated satisfaction with their prosthesis using a visual analog scale (VAS)Regarding VAS, participants were asked to score their answer according to the amount of satisfaction on a 100 mm line (Score 0 = no satisfaction at all and score 100 = complete satisfaction). The questions cover several items related to overdentures such as retention, stability, comfort, ease of cleaning, ease of speaking, ease of chewing, limited activities due to embarrassment, quality of bolus, and appearance. , and oral health impact profile (OHIP-14) was recorded for both prostheses. The Wilcoxon signed-rank test was done to compare the statistically significant difference between the two groups. SPSS ver.23. P \<.05 was considered significant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 12, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 7, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 7, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2025

Completed
6 months until next milestone

First Posted

Study publicly available on registry

July 1, 2025

Completed
Last Updated

July 1, 2025

Status Verified

January 1, 2023

Enrollment Period

1.5 years

First QC Date

January 10, 2025

Last Update Submit

June 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • patients indicated satisfaction with their prosthesis using a visual analog scale (VAS)

    3 months

Secondary Outcomes (1)

  • oral health impact profile (OHIP-14) was recorded for both prostheses.

    3 months

Study Arms (2)

implant retained group

ACTIVE COMPARATOR

two implants in molar position and two remaining canines

Other: implant retained overdenture prosthesis

implant tooth retained group

ACTIVE COMPARATOR

implant in molar position and two remaining canines

Other: implant canine retained overdenture prosthesis

Interventions

implant retained only prosthesis

implant retained group

prosthesis retention from implant and canine

implant tooth retained group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • This research will be done on patients who were previously received 2 mesially placed implants in the 1st premolar region with only two remaining mandibular canines with opposing maxillary single denture

You may not qualify if:

  • uncontrolled diabetic patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Basmsa

Al Mansurah, 35516, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2025

First Posted

July 1, 2025

Study Start

January 12, 2023

Primary Completion

July 7, 2024

Study Completion

August 7, 2024

Last Updated

July 1, 2025

Record last verified: 2023-01

Locations